NDC 50090-4560-01 - Enalapril Maleate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-4560
- Requested NDC
- 50090-4560-01
- Package NDCs from labels
- 50090-4560-0, 50090-4560-1, 50090-4560-3, 50090-4560-2, 50090-4560-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-01-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enalapril Maleate - A-S Medication Solutions | A-S Medication Solutions | 2026-01-06 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50090-4560-0 | 2023-05-08 | Enalapril Maleate Tablets, USP |
| 50090-4560-1 | 2023-05-08 | Enalapril Maleate Tablets, USP |
| 50090-4560-3 | 2023-05-08 | Enalapril Maleate Tablets, USP |
| 50090-4560-0 | 2023-01-30 | Enalapril Maleate Tablets, USP |
| 50090-4560-1 | 2023-01-30 | Enalapril Maleate Tablets, USP |
| 50090-4560-3 | 2023-01-30 | Enalapril Maleate Tablets, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-4560-0 | Enalapril Maleate | 30 in 1 BOTTLE | TABLET | 30 | 7 | |
| 50090-4560-1 | Enalapril Maleate | 60 in 1 BOTTLE | TABLET | 60 | 7 | |
| 50090-4560-2 | Enalapril Maleate | 1000 in 1 BOTTLE | TABLET | 1000 | 7 | |
| 50090-4560-3 | Enalapril Maleate | 90 in 1 BOTTLE | TABLET | 90 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-4560 | ENALAPRIL MALEATE TABLET [A-S MEDICATION SOLUTIONS] | 5 | Current NDC, Legacy NDC, 4 package rows | 20230510_bc875f91-d781-43a9-8f7e-e2cfc019ad3f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-4560-0 | EA - Each | 50090-4560 | 0eac2391-7274-446a-9fec-4ef0ffe9f2f3 | 1 | 2023-06-06 |
| 50090-4560-1 | EA - Each | 50090-4560 | 914bc84c-846c-4e3b-a7ba-8fd265fcec31 | 1 | 2022-12-07 |
| 50090-4560-3 | EA - Each | 50090-4560 | 04557f2f-0fe9-4421-bde9-cb3e90415a45 | 1 | 2022-12-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zegerid OTC | OMEPRAZOLE, SODIUM BICARBONATE | Riley Consumer Care LLC | 1d764fc5-8eae-4fc9-a2e9-3f1954a3ac05 | 2025-12-24 | Warnings | 8MDF5V39QO |
| BABY ANTI MONKEY BUTT DIAPER RASH | ZINC OXIDE, CALAMINE | Clarion Brands, LLC | e4424d74-f89c-5943-42e8-bf3a38e68619 | 2025-12-23 | Warnings | 1K09F3G675 |
| SODIUM BICARBONATE | SODIUM BICARBONATE | ProPharma Distribution | 3867f743-c2cf-a646-e063-6394a90a82e1 | 2025-12-18 | Warnings, Adverse reactions | 8MDF5V39QO |
| Enalapril maleate | ENALAPRIL MALEATE | Wilshire Pharmaceuticals, Inc. | c7934b45-eb6b-44c1-bd2c-ef0fa10850c1 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| Epaned | ENALAPRIL MALEATE | Azurity Pharmaceuticals, Inc. | e6dbda02-779e-420c-893d-d0fea09432be | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| SinuCleanse | SODIUM BICARBONATE, SODIUM CHLORIDE | ASCENT CONSUMER PRODUCTS, INC. | beb842fa-2373-4f21-9631-ef20ee124584 | 2025-12-10 | Warnings | 8MDF5V39QO |
| All natural Saline Packets CareOne | SODIUM BICARBONATE, SODIUM CHLORIDE | FOODHOLD U.S.A. | e32f105d-65cd-8095-e053-2995a90a9b6b | 2025-12-10 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Heartburn | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | Bayer HealthCare LLC. | 55158e50-0327-2043-e054-00144ff8d46c | 2025-12-04 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Extra Strength | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE, AND ASPIRIN | Bayer HealthCare LLC. | 49b73bd5-6465-05eb-e054-00144ff88e88 | 2025-12-04 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Gold | ALKA-SELTZER GOLD | Bayer HealthCare LLC. | 0824bedb-413b-2fa0-e054-00144ff88e88 | 2025-12-04 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Bayer HealthCare LLC. | 5be36a7f-7d1f-468d-9c29-92c8cd3ef1bc | 2025-12-04 | Warnings | 8MDF5V39QO |
| OMEPRAZOLE AND SODIUM BICARBONATE | OMEPRAZOLE AND SODIUM BICARBONATE | Aurohealth LLC | 88ad2e92-2228-49b2-bcee-1770fd30cb14 | 2025-12-04 | Warnings | 8MDF5V39QO |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Ajanta Pharma USA Inc. | bd84ca00-6352-4cb3-bce2-05f4a5005a94 | 2025-11-30 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Civica | a10fdfbc-94a0-49ab-b26c-de1df042bc89 | 2025-11-24 | Warnings, Adverse reactions | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Glenmark Pharmaceuticals Inc., USA | f38d0dfc-9bcc-4224-a202-885c9ad0beae | 2025-11-20 | Warnings, Adverse reactions | 8MDF5V39QO |
| Itch Eraser Sensitive | SODIUM BICARBONATE | Tender Corporation d/b/a Adventure Ready Brands | 2250525a-45c2-42ea-e063-6394a90ac001 | 2025-11-18 | Warnings | 8MDF5V39QO |
| After Bite Kids | SODIUM BICARBONATE | Tender Corporation d/b/a Adventure Ready Brands | 226c1420-d771-204f-e063-6294a90af9f6 | 2025-11-18 | Warnings | 8MDF5V39QO |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | R J General Corporation | dbb0d067-71f0-45e4-bc98-548cf4a90b3a | 2025-11-17 | Warnings | 8MDF5V39QO |
| After Bite X Tech | SODIUM BICARBONATE | Adventure Ready Brands | e9e49ab4-3e1f-9fd4-e053-2a95a90a775a | 2025-11-17 | Warnings | 8MDF5V39QO |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Kroger Co. | 6b3e7aac-395f-48cf-9c5e-f7e163724aef | 2025-11-17 | Warnings | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.